Drug intelligence / Profile preview

dexamethasone + lidocaine

Development stage
Phase 4
Lead developer
Nubratori
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, Injectable, Intravenous, Infiltration
01

Overview

Dexamethasone + lidocaine is a combination drug consisting of dexamethasone, a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressant properties, and lidocaine, an amide-type local anesthetic that provides rapid pain relief by blocking sodium channels in neuronal membranes. This combination is used to provide both immediate analgesia (from lidocaine) and longer-term anti-inflammatory effects (from dexamethasone). It has been studied for use in perioperative pain management (e.g., reducing injection pain during propofol administration), oral inflammatory conditions such as mucositis or lichen planus, and as an adjuvant in regional anesthesia[2][5][7]. Dexamethasone acts primarily via activation of the glucocorticoid receptor to inhibit pro-inflammatory gene expression and reduce leukocyte migration; lidocaine blocks voltage-gated sodium channels to prevent nerve impulse conduction[9][10].

Brand names
LIDOCIDEX-IReadySharp Anesthetics Plus Dexamethasone
Other names
dexamethasone sodium phosphate/lidocaine HCldexamethasone + lidocaine oral rinse
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on dexamethasone + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + lidocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call